New Histone H3 [dimethyl Lys9/phospho Thr6] Antibody Released

Today, Novus added a new Histone H3 [dimethyl Lys9/phospho Thr6] antibody to their growing line of EpiPlusTM histone modification antibodies. Over the past several months, Novus has collaborated with 21st Century Biochemicals, a leading manufacturer of custom antibodies and peptides, to generate the most well validated antibodies for modified histones and other epigenetic targets.  All Epi-PlusTM antibodies have been extensively characterized and validated, and are of the highest quality compared to other similarly commercially available products.

Although dimethyl K9, phospho-T6 histone H3 is known to exist, very little comprehensive information about the importance of this modification and its mechanism has been published. The new Histone H3 [dimethyl Lys9/phospho Thr6] Antibody (NB21-1053) has been validated for Western blot, ChIP, dot blot, and immunofluorescent staining on human, mouse and rat cell cultures. This highly specific antibody is expected to accelerate research on a poorly understood antigen and progress epigenetics research on this target.

About Novus Biologicals (

Novus Biologicals is a biotechnology company whose mission is to accelerate scientific discovery by developing and marketing unique products in the forefront of science.  Novus Biologicals provides primary antibodies, secondary antibodies, conjugated antibodies, proteins, peptides, isotype and loading controls, RNAi, lysates, stem cell lines and antibody labeling kits to the bioscience community.  All of Novus' products are 100% guaranteed to work in the species and applications listed on the datasheet.  By serving niche and emerging markets, Novus Biologicals has formed and will continue to form ongoing partnerships with leading researchers.

About 21st Century Biochemicals (

21st Century Biochemicals provides solutions for biomedical researchers worldwide ranging from the manufacture of polyclonal and monoclonal antibodies to custom and bioactive peptides, arrays, libraries and peptidomimetics.  Consisting of a core of PhD scientists with decades of experience, 21st Century Biochemicals provides peptide and antibody solutions with the most rigorous peptide QC in the industry:  nanospray MS and HPLC analysis as well as CID MS/MS peptide sequence confirmation.    100% of the peptides and antibodies provided by 21st Century Biochemicals are manufactured in their facility outside of Boston, MA, providing unmatched product quality and consistency.

Release Date: 
Monday, September 19, 2011 - 06:00